SITC 2018 workshop report: Immuno-Oncology Biomarkers: State of the Art

Identification of biomarkers in cancer immunotherapy that predict therapeutic response and/or limit adverse events are a critical need in the field. To address recent progress and hurdles around cancer biomarker development and utilization, the Society for Immunotherapy of Cancer (SITC) convened a w...

Descripción completa

Detalles Bibliográficos
Autores principales: Butterfield, Lisa H., Disis, Mary L., Fox, Bernard A., Kaufman, David R., Khleif, Samir N., Wang, Ena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278162/
https://www.ncbi.nlm.nih.gov/pubmed/30514399
http://dx.doi.org/10.1186/s40425-018-0453-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278162/
https://www.ncbi.nlm.nih.gov/pubmed/30514399
http://dx.doi.org/10.1186/s40425-018-0453-4

Ejemplares similares